India's Diagnostics Industry
Price Wars and Consolidation
How new entrants and online platforms sparked price wars in diagnostics, and how chains consolidated through acquisitions.
Diagnostics has become competitive.
New entrants
After COVID, online platforms, hospital chains and startups entered.
Price wars
Discounts squeezed margins for established chains.
Acquisitions
- PharmEasy bought Thyrocare in 2021.
- Metropolis acquired Hitech Diagnostics.
- Apollo and Reliance expanded diagnostics.
Share prices
Lab stocks fell from COVID-era highs.
Moats
Brand, trust and doctor relationships remain key.
The acquisition
An online pharmacy buys a large lab chain to offer tests alongside medicines.
Thinking diagnostics is easy money
Competition squeezed margins.
Key takeaways
- New entrants sparked price wars.
- PharmEasy bought Thyrocare in 2021.
- Chains consolidated.
- Brand and trust remain key.
No recording for this one yet - EconReader can read it aloud for you.